Cargando…

Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study

OBJECTIVES: We aimed to investigate clinical uncertainties by characterizing the accuracy and utility of commercially available antibodies of Mycobacterium tuberculosis in the diagnostic assessment of suspected tuberculosis in high-burden countries. METHODS: We conducted a retrospective, descriptive...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, DeWu, Liang, ChaoJuan, Huang, XiaoXian, Pan, HuiDan, Qin, Yue, Shi, XiMing, Tang, YunHua, Wang, Ying, Zhao, MingMei, Lin, JianYan, Xie, ZhouHua, Wen, LeMin, Chen, ChaoYou, Tang, XiKe, Luo, XiaoCheng, Shao, HongHua, Luo, XiaoLu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364559/
https://www.ncbi.nlm.nih.gov/pubmed/37477876
http://dx.doi.org/10.1080/07853890.2023.2238186
_version_ 1785076869609029632
author Bi, DeWu
Liang, ChaoJuan
Huang, XiaoXian
Pan, HuiDan
Qin, Yue
Shi, XiMing
Tang, YunHua
Wang, Ying
Zhao, MingMei
Lin, JianYan
Xie, ZhouHua
Wen, LeMin
Chen, ChaoYou
Tang, XiKe
Luo, XiaoCheng
Shao, HongHua
Luo, XiaoLu
author_facet Bi, DeWu
Liang, ChaoJuan
Huang, XiaoXian
Pan, HuiDan
Qin, Yue
Shi, XiMing
Tang, YunHua
Wang, Ying
Zhao, MingMei
Lin, JianYan
Xie, ZhouHua
Wen, LeMin
Chen, ChaoYou
Tang, XiKe
Luo, XiaoCheng
Shao, HongHua
Luo, XiaoLu
author_sort Bi, DeWu
collection PubMed
description OBJECTIVES: We aimed to investigate clinical uncertainties by characterizing the accuracy and utility of commercially available antibodies of Mycobacterium tuberculosis in the diagnostic assessment of suspected tuberculosis in high-burden countries. METHODS: We conducted a retrospective, descriptive, cohort study among participants aged ≥ 18 years with suspected tuberculosis in Nanning, Guangxi, and China. Participants were tested for M. tuberculosis infection using commercially available antibodies against Mycobacterum tuberculosis. Specificity, sensitivity, negative and positive predictive values, and negative and positive likelihood ratios of the tests were determined. Sputum specimens and bronchoalveolar lavage fluid were sent for mycobacterial culture, Xpert MTB/RIF assay, and cell-free M. tuberculosis DNA or RNA assay. Blood samples were used for IGRAs, T-cell counts (CD3 + CD4+ and CD3 + CD8+), and antibodies to tuberculosis test. RESULTS: Of the 1857 participants enrolled in this study, 1772 were included in the analyses, among which, 1311 were diagnosed with active tuberculosis. The specificity of antibody against 16kD for active tuberculosis was 92.7% (95% confidence interval [CI]: 89.3–95.4) with a positive likelihood ratio for active tuberculosis cases of 3.1 (95% CI: 2.1–4.7), which was higher than that of antibody to Rv1636 (90.5% [95% CI: 86.6–93.5]), antibody to 38kD (89.5% [95% CI: 85.5–92.7]), antibody against CFP-10 (82.6% [95% CI: 77.9–86.7]), and antibody against LAM (79.3% [95% CI: 74.3–83.7]). Sensitivity ranged from 15.8% (95% CI: 13.9–17.9) for antibody against Rv1636 to 32.9% (95% CI: 30.4–35.6) for antibody to LAM. CONCLUSIONS: Commercially available antibodies against to Mycobacterium tuberculosis do not have sufficient sensitivity for the diagnostic evaluation of active tuberculosis. However, antibody against Rv1636 and 16kD may have sufficiently high specificities, high positive likelihood ratios, and correspondingly high positive predictive values to facilitate the rule-in of active tuberculosis.
format Online
Article
Text
id pubmed-10364559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-103645592023-07-25 Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study Bi, DeWu Liang, ChaoJuan Huang, XiaoXian Pan, HuiDan Qin, Yue Shi, XiMing Tang, YunHua Wang, Ying Zhao, MingMei Lin, JianYan Xie, ZhouHua Wen, LeMin Chen, ChaoYou Tang, XiKe Luo, XiaoCheng Shao, HongHua Luo, XiaoLu Ann Med Infectious Diseases OBJECTIVES: We aimed to investigate clinical uncertainties by characterizing the accuracy and utility of commercially available antibodies of Mycobacterium tuberculosis in the diagnostic assessment of suspected tuberculosis in high-burden countries. METHODS: We conducted a retrospective, descriptive, cohort study among participants aged ≥ 18 years with suspected tuberculosis in Nanning, Guangxi, and China. Participants were tested for M. tuberculosis infection using commercially available antibodies against Mycobacterum tuberculosis. Specificity, sensitivity, negative and positive predictive values, and negative and positive likelihood ratios of the tests were determined. Sputum specimens and bronchoalveolar lavage fluid were sent for mycobacterial culture, Xpert MTB/RIF assay, and cell-free M. tuberculosis DNA or RNA assay. Blood samples were used for IGRAs, T-cell counts (CD3 + CD4+ and CD3 + CD8+), and antibodies to tuberculosis test. RESULTS: Of the 1857 participants enrolled in this study, 1772 were included in the analyses, among which, 1311 were diagnosed with active tuberculosis. The specificity of antibody against 16kD for active tuberculosis was 92.7% (95% confidence interval [CI]: 89.3–95.4) with a positive likelihood ratio for active tuberculosis cases of 3.1 (95% CI: 2.1–4.7), which was higher than that of antibody to Rv1636 (90.5% [95% CI: 86.6–93.5]), antibody to 38kD (89.5% [95% CI: 85.5–92.7]), antibody against CFP-10 (82.6% [95% CI: 77.9–86.7]), and antibody against LAM (79.3% [95% CI: 74.3–83.7]). Sensitivity ranged from 15.8% (95% CI: 13.9–17.9) for antibody against Rv1636 to 32.9% (95% CI: 30.4–35.6) for antibody to LAM. CONCLUSIONS: Commercially available antibodies against to Mycobacterium tuberculosis do not have sufficient sensitivity for the diagnostic evaluation of active tuberculosis. However, antibody against Rv1636 and 16kD may have sufficiently high specificities, high positive likelihood ratios, and correspondingly high positive predictive values to facilitate the rule-in of active tuberculosis. Taylor & Francis 2023-07-21 /pmc/articles/PMC10364559/ /pubmed/37477876 http://dx.doi.org/10.1080/07853890.2023.2238186 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Infectious Diseases
Bi, DeWu
Liang, ChaoJuan
Huang, XiaoXian
Pan, HuiDan
Qin, Yue
Shi, XiMing
Tang, YunHua
Wang, Ying
Zhao, MingMei
Lin, JianYan
Xie, ZhouHua
Wen, LeMin
Chen, ChaoYou
Tang, XiKe
Luo, XiaoCheng
Shao, HongHua
Luo, XiaoLu
Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
title Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
title_full Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
title_fullStr Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
title_full_unstemmed Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
title_short Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
title_sort clinical utilization of multiple antibodies of mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364559/
https://www.ncbi.nlm.nih.gov/pubmed/37477876
http://dx.doi.org/10.1080/07853890.2023.2238186
work_keys_str_mv AT bidewu clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT liangchaojuan clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT huangxiaoxian clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT panhuidan clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT qinyue clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT shiximing clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT tangyunhua clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT wangying clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT zhaomingmei clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT linjianyan clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT xiezhouhua clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT wenlemin clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT chenchaoyou clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT tangxike clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT luoxiaocheng clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT shaohonghua clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy
AT luoxiaolu clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy